Pedestrian fatality risk as a function of car impact speed.

Accid Anal Prev

Autoliv Research, Wallentinsvägen 22, 447 83, Vårgårda, Sweden.

Published: May 2009

Knowledge of the amount of violence tolerated by the human body is essential when developing and implementing pedestrian safety strategies. When estimating the potential benefits of new countermeasures, the pedestrian fatality risk as a function of impact speed is of particular importance. Although this function has been analysed previously, we state that a proper understanding does not exist. Based on the largest in-depth, pedestrian accident study undertaken to date, we derive an improved risk function for adult pedestrians hit by the front of passenger cars. Our results show far lower fatality risks than generally reported in the traffic safety literature. This discrepancy is primarily explained by sample bias towards severe injury accidents in earlier studies. Nevertheless, a strong dependence on impact speed is found, with the fatality risk at 50 km/h being more than twice as high as the risk at 40 km/h and more than five times higher than the risk at 30 km/h. Our findings should have important implications for the development of pedestrian accident countermeasures worldwide. In particular, the scope of future pedestrian safety policies and research should be broadened to include accidents with impact speeds exceeding 50 km/h.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aap.2009.02.002DOI Listing

Publication Analysis

Top Keywords

fatality risk
12
risk function
12
impact speed
12
risk km/h
12
pedestrian fatality
8
pedestrian safety
8
pedestrian accident
8
pedestrian
6
risk
6
function
4

Similar Publications

Purpose: Heart failure (HF) is a disease that leads to approximately 300,000 fatalities annually in Europe and 250,000 deaths each year in the United States. Type 2 Diabetes Mellitus (T2DM) is a significant risk factor for HF, and testing for N-terminal (NT)-pro hormone BNP (NT-proBNP) can aid in early detection of HF in T2DM patients. We therefore developed and validated the HFriskT2DM-HScore, an algorithm to predict the risk of HF in T2DM patients, so guiding NT-proBNP investigation in a primary care setting.

View Article and Find Full Text PDF

Omics approaches: Role in acute myeloid leukemia biomarker discovery and therapy.

Cancer Genet

January 2025

PhD of Hematology, Assistant Professor, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address:

Acute myeloid leukemia (AML) is the most common acute leukemia in adults and has the highest fatality rate. Patients aged 65 and above exhibit the poorest prognosis, with a mere 30 % survival rate within one year. One important issue in optimizing outcomes for AML patients is their limited ability to predict responses to specific therapies, response duration, and likelihood of relapse.

View Article and Find Full Text PDF

Holter electrocardiography findings in Fukuyama congenital muscular dystrophy.

Neuromuscul Disord

January 2025

Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan; Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Fukuyama congenital muscular dystrophy (FCMD) is the second most common childhood-onset muscular dystrophy in Japan. However, only a few comprehensive studies have investigated cardiac complications associated with FCMD, with none on arrhythmias. The present study evaluated 78 Holter electrocardiograms from 15 patients with FCMD.

View Article and Find Full Text PDF

Background: Non-small cell lung cancer (NSCLC) is a fatal disease, and radioresistance is an important factor leading to treatment failure and disease progression. The objective of this research was to detect radioresistance-related genes (RRRGs) with prognostic value in NSCLC.

Methods: The weighted gene coexpression network analysis (WGCNA) and differentially expressed genes (DEGs) analysis were performed to identify RRRGs using expression profiles from TCGA and GEO databases.

View Article and Find Full Text PDF

Expert-Based Narrative Review on Compression UltraSonography (CUS) for Diagnosis and Follow-Up of Deep Venous Thrombosis (DVT).

Diagnostics (Basel)

January 2025

Research Center on Thromboembolic Diseases and Antithrombotic Treatment, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.

Deep venous thrombosis (DVT) is a pathological condition that develops when a thrombus forms within the deep venous system. Typically, it involves the lower limbs and, less frequently, the upper extremities or other unusual districts such as cerebral or splanchnic veins. While leg DVT itself is rarely fatal and occasionally can lead to limb-threatening implications, its most fearsome complication, namely pulmonary embolism, is potentially fatal and significantly contributes to increased healthcare costs and impaired quality of life in affected patients and caregivers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!